Lewis H. Titterton Jr.

CIK: 0001499254

Transaction Breakdown

Open Market Buys (P)14 (48.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (13.8%)

Derivative conversions

Awards (A)6 (20.7%)

Compensation grants

Other (G, F, J, C, D, …)5 (17.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ANIX

Anixa Biosciences Inc

Director

PRKR

PARKERVISION INC

Director

Discretionary Trading P&L

Holdings

Transaction History (29 total)

ANIX
Anixa Biosciences Inc
Oct 23, 2026
Purchase(P)
Direct
8K shares at avg. $2.98$24K
ANIX
Anixa Biosciences Inc
Sep 23, 2026
Purchase(P)
Direct
49K shares at avg. $2.69$132K
ANIX
Anixa Biosciences Inc
Sep 10, 2026
Purchase(P)
Direct
10K shares at avg. $2.73$27K
ANIX
Anixa Biosciences Inc
Jul 20, 2026
Purchase(P)
Direct
12K shares at avg. $3.47$42K
ANIX
Anixa Biosciences Inc
Jul 15, 2026
Purchase(P)
Direct
2.8K shares at avg. $3.28$9K
ANIX
Anixa Biosciences Inc
Jun 16, 2026
Purchase(P)
Direct
2.8K shares at avg. $2.64$7K
PRKR
PARKERVISION INC
Jan 22, 2026
Award(A)
Option to Purchase Common Stock
Direct
370K shares at avg. $0.24-
ANIX
Anixa Biosciences Inc
Jan 5, 2026
Award(A)
Employee Stock Option
Direct
25K shares-
ANIX
Anixa Biosciences Inc
Dec 15, 2025
Exercise(M)
Direct
16K shares at avg. $2.92$47K
PRKR
PARKERVISION INC
Nov 18, 2025
Purchase(P)
Direct
4.8M shares at avg. $0.21$1.0M
PRKR
PARKERVISION INC
Oct 7, 2025
Exercise(M)
Direct
525K shares at avg. $0.18$95K
PRKR
PARKERVISION INC
Oct 7, 2025
Exercise(M)
Direct
275K shares at avg. $0.20$55K
ANIX
Anixa Biosciences Inc
Jul 31, 2025
Purchase(P)
Direct
10K shares at avg. $3.08$31K
ANIX
Anixa Biosciences Inc
Jul 11, 2025
Purchase(P)
Direct
10K shares at avg. $3.14$31K
PRKR
PARKERVISION INC
Jul 3, 2025
Award(A)
Direct
275K shares-
PRKR
PARKERVISION INC
May 6, 2025
Conversion(C)
Direct
1.7M shares at avg. $0.13$221K
ANIX
Anixa Biosciences Inc
Jan 24, 2025
Purchase(P)
Direct
1K shares at avg. $3.00$3K
ANIX
Anixa Biosciences Inc
Jan 23, 2025
Purchase(P)
Direct
2K shares at avg. $2.91$6K
ANIX
Anixa Biosciences Inc
Jan 22, 2025
Purchase(P)
Direct
2K shares at avg. $3.01$6K
ANIX
Anixa Biosciences Inc
Jan 21, 2025
Purchase(P)
Direct
6K shares at avg. $2.59$16K
ANIX
Anixa Biosciences Inc
Jan 17, 2025
Purchase(P)
Direct
10K shares at avg. $2.57$26K
PRKR
PARKERVISION INC
Jan 6, 2025
Gift(G)
Direct
2M shares-
ANIX
Anixa Biosciences Inc
Jan 2, 2025
Award(A)
Employee Stock Option
Direct
25K shares-
PRKR
PARKERVISION INC
Dec 31, 2024
Award(A)
Direct
29.4K shares at avg. $0.17$5K
PRKR
PARKERVISION INC
Dec 31, 2024
Award(A)
Direct
8.6K shares at avg. $0.17$1K

		Type	Shares	Price		Ownership
Oct 23, 2026	ANIX Anixa Biosciences Inc	Purchase(P)	8,000	$2.98	$23,840	Direct
Sep 23, 2026	ANIX Anixa Biosciences Inc	Purchase(P)	49,036	$2.69	$131,907	Direct
Sep 10, 2026	ANIX Anixa Biosciences Inc	Purchase(P)	10,000	$2.73	$27,300	Direct
Jul 20, 2026	ANIX Anixa Biosciences Inc	Purchase(P)	12,000	$3.47	$41,640	Direct
Jul 15, 2026	ANIX Anixa Biosciences Inc	Purchase(P)	2,797	$3.28	$9,174	Direct
Jun 16, 2026	ANIX Anixa Biosciences Inc	Purchase(P)	2,836	$2.64	$7,487	Direct
Jan 22, 2026	PRKR PARKERVISION INC	Award(A) Option to Purchase Common Stock	370,000	$0.24	-	Direct
Jan 5, 2026	ANIX Anixa Biosciences Inc	Award(A) Employee Stock Option	25,000	-	-	Direct
Dec 15, 2025	ANIX Anixa Biosciences Inc	Exercise(M)	16,000	$2.92	$46,720	Direct
Nov 18, 2025	PRKR PARKERVISION INC	Purchase(P)	4,761,905	$0.21	$1,000,000	Direct
Oct 7, 2025	PRKR PARKERVISION INC	Exercise(M)	525,000	$0.18	$94,500	Direct
Oct 7, 2025	PRKR PARKERVISION INC	Exercise(M)	275,000	$0.20	$55,000	Direct
Jul 31, 2025	ANIX Anixa Biosciences Inc	Purchase(P)	10,000	$3.08	$30,800	Direct
Jul 11, 2025	ANIX Anixa Biosciences Inc	Purchase(P)	10,000	$3.14	$31,400	Direct
Jul 3, 2025	PRKR PARKERVISION INC	Award(A)	275,000	-	-	Direct
May 6, 2025	PRKR PARKERVISION INC	Conversion(C)	1,699,844	$0.13	$220,980	Direct
Jan 24, 2025	ANIX Anixa Biosciences Inc	Purchase(P)	1,000	$3.00	$3,000	Direct
Jan 23, 2025	ANIX Anixa Biosciences Inc	Purchase(P)	2,000	$2.91	$5,820	Direct
Jan 22, 2025	ANIX Anixa Biosciences Inc	Purchase(P)	2,000	$3.01	$6,020	Direct
Jan 21, 2025	ANIX Anixa Biosciences Inc	Purchase(P)	6,000	$2.59	$15,540	Direct
Jan 17, 2025	ANIX Anixa Biosciences Inc	Purchase(P)	10,000	$2.57	$25,700	Direct
Jan 6, 2025	PRKR PARKERVISION INC	Gift(G)	2,000,000	-	$0	Direct
Jan 2, 2025	ANIX Anixa Biosciences Inc	Award(A) Employee Stock Option	25,000	-	-	Direct
Dec 31, 2024	PRKR PARKERVISION INC	Award(A)	29,413	$0.17	$5,000	Direct
Dec 31, 2024	PRKR PARKERVISION INC	Award(A)	8,568	$0.17	$1,499	Direct

1-25 of 29 transactions

About Titterton Lewis H jr

Titterton Lewis H jr (SEC CIK 0001499254) files insider reports with the SEC as Director of Anixa Biosciences Inc (ANIX) and Director of PARKERVISION INC (PRKR).

Signal8 holds 23 ownership filings by Titterton Lewis H jr, all Form 4s, filed between Sep 25, 2024 and Oct 26, 2026. Those filings report 29 transactions, from Sep 24, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Titterton Lewis H jr's filings is in SAN JOSE, CA.

Recent filings by Titterton Lewis H jr

Oct 23, 2026: Open-market purchase of ANIX shares (Form 4, code P).
Sep 23, 2026: Open-market purchase of ANIX shares (Form 4, code P).
Sep 10, 2026: Open-market purchase of ANIX shares (Form 4, code P).
Jul 20, 2026: Open-market purchase of ANIX shares (Form 4, code P).
Jul 15, 2026: Open-market purchase of ANIX shares (Form 4, code P).

Other insiders filing for Anixa Biosciences Inc (ANIX)

KUMAR AMIT, Chief Executive Officer
Baskies Arnold M, Director
Gottschalk Emily, Director
Catelani Michael, President, COO & CFO

How to read Form 4 transaction codes